Evidence map›Paper›PMID 24466051›Full record

ArticlePloS one2014

Deletion of individual Ku subunits in mice causes an NHEJ-independent phenotype potentially by altering apurinic/apyrimidinic site repair.

Yong Jun Choi, Han Li, Mi Young Son, Xiao-Hong Wang, Jamie L Fornsaglio, Robert W Sobol, Moonsook Lee, Jan Vijg, Sandra Imholz, Martijn E T Dollé and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Yong Jun ChoiDepartment of Molecular Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
Han LiDepartment of Molecular Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
Mi Young SonDepartment of Molecular Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
Xiao-Hong WangDepartment of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Jamie L FornsaglioDepartment of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Robert W SobolDepartment of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America ; Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States of America ; Department of Human Genetics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, United States of America.
Moonsook LeeDepartment of Genetics, Albert Einstein College of Medicine, Bronx, New York, United States of America.
Jan VijgDepartment of Genetics, Albert Einstein College of Medicine, Bronx, New York, United States of America.
Sandra ImholzCenter for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Martijn E T DolléCenter for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Harry van SteegCenter for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Erwin ReilingCenter for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands ; MGC Department of Cell Biology and Genetics, Center for Biomedical Genetics, Erasmus MC, Rotterdam, The Netherlands.
Paul HastyDepartment of Molecular Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America.
National Institute for Public Health and the Environment · NLThe University of Texas Health Science Center at San Antonio · USUniversity of Pittsburgh · USAlbert Einstein College of Medicine · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI STEVEN C. ALMO · 1985 to 2026
$111.2M
TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Robin Jean Leach · 1991 to 2026
$59.1M
THE IMPACT OF CELLULAR DEFENSE ON THE ROLE OF Ku80 IN GENOME MAINTENANCE AND LONGP01AG017242 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI VIJG, JAN · 1999 to 2023
$46.1M
Models for DNA repair and cell cycle control variantsU01ES011044 · NIEHS · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI VIJG, JAN · 2001 to 2006
$5.1M
Novel approaches to enhance tumor cell cytotoxicity of alkylating agentsR01CA148629 · NCI · UNIVERSITY OF SOUTH ALABAMA · PI SOBOL, ROBERT W · 2010 to 2021
$3.4M
DNA repair deficient cells for analysisR44GM087798 · NIGMS · TREVIGEN, INC. · PI GEORGE, JAY, SOBOL, ROBERT W · 2010 to 2011
$2.5M
XRCC5 MUTANT MICE AND CELL LINESR01CA076317 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI HASTY, EDWARD PAUL · 1997 to 2005
$1.0M
CometChip: Enabling Translation of DNA Damage and Repair AssaysR21ES019498 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ENGELWARD, BEVIN P., SOBOL, ROBERT W · 2011 to 2012
$434k
DNA repair deficient human cells for genomic variation analysisR43GM087798 · NIGMS · TREVIGEN, INC. · PI GEORGE, JAY, SOBOL, ROBERT W · 2009 to 2009
$200k
NCI NIH HHS CA054174NCI NIH HHS CA148629NCI NIH HHS P30 CA013330NCI NIH HHS P30 CA054174NCI NIH HHS R01 CA076317NCI NIH HHS R01 CA148629NCI NIH HHS R01 CA76317-05A1NIA NIH HHS P01 AG017242NIA NIH HHS P01 AG17242NIEHS NIH HHS ES019498NIEHS NIH HHS R21 ES019498NIEHS NIH HHS U01 ES011044NIEHS NIH HHS UO1 ES11044NIGMS NIH HHS GM087798NIGMS NIH HHS R43 GM087798NIGMS NIH HHS R44 GM087798
6 · The paper itself

Abstract

Ku70 and Ku80 form a heterodimer called Ku that forms a holoenzyme with DNA dependent-protein kinase catalytic subunit (DNA-PKCS) to repair DNA double strand breaks (DSBs) through the nonhomologous end joining (NHEJ) pathway. As expected mutating these genes in mice caused a similar DSB repair-defective phenotype. However, ku70(-/-) cells and ku80(-/-) cells also appeared to have a defect in base excision repair (BER). BER corrects base lesions, apurinic/apyrimidinic (AP) sites and single stand breaks (SSBs) utilizing a variety of proteins including glycosylases, AP endonuclease 1 (APE1) and DNA Polymerase β (Pol β). In addition, deleting Ku70 was not equivalent to deleting Ku80 in cells and mice. Therefore, we hypothesized that free Ku70 (not bound to Ku80) and/or free Ku80 (not bound to Ku70) possessed activity that influenced BER. To further test this hypothesis we performed two general sets of experiments. The first set showed that deleting either Ku70 or Ku80 caused an NHEJ-independent defect. We found ku80(-/-) mice had a shorter life span than dna-pkcs(-/-) mice demonstrating a phenotype that was greater than deleting the holoenzyme. We also found Ku70-deletion induced a p53 response that reduced the level of small mutations in the brain suggesting defective BER. We further confirmed that Ku80-deletion impaired BER via a mechanism that was not epistatic to Pol β. The second set of experiments showed that free Ku70 and free Ku80 could influence BER. We observed that deletion of either Ku70 or Ku80, but not both, increased sensitivity of cells to CRT0044876 (CRT), an agent that interferes with APE1. In addition, free Ku70 and free Ku80 bound to AP sites and in the case of Ku70 inhibited APE1 activity. These observations support a novel role for free Ku70 and free Ku80 in altering BER.

Indexed as

DNA End-Joining RepairAnimalsAntigens, NuclearApurinic AcidDNA-Activated Protein KinaseDNA-(Apurinic or Apyrimidinic Site) LyaseDNA-Binding ProteinsEpistasis, GeneticFemaleGene DeletionIndolesKu AutoantigenLongevityMaleMiceMice, Inbred C57BL7-nitro-1H-indole-2-carboxylic acidAntigens, NuclearApex1 protein, mouseApurinic AcidDNA-Activated Protein KinaseDNA-(Apurinic or Apyrimidinic Site) LyaseDNA-Binding ProteinsIndolesKu AutoantigenNuclear ProteinsPrkdc protein, mouseProtein SubunitsTumor Suppressor Protein p53Xrcc6 protein, humanXrcc6 protein, mouse

Identifiers

PMID24466051
PMCPMC3900520
OpenAlexW2080118748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.